Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show

World News: . []

Novartis International AG Cosentyx LINK  long-lasting inhibition of radiographic progression in psoriatic arthritis new LINK  data show Processed and transmitted by West CorporationThe issuer is LINK  responsible for the content of this a...

More news and information about Novartis International AG

Published By:

Thomson Reuters: 06:20 GMT Wednesday 12th June 2019

Published: .

Search for other references to "cosentyx" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us